A new way to control urban disease-carrying insects
An immune system for the city: a new paradigm for control of urban disease vectors
This study is testing a new way to help communities in Arequipa, Peru, work together to control pesky insects like bedbugs by using ideas inspired by how our immune system fights off germs, and it will compare this approach to the usual pest control methods.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pennsylvania NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-10642860 on NIH RePORTER |
What this research studies
This research investigates a novel approach to managing dangerous urban insects, such as bedbugs, by modeling strategies after the human immune system. It aims to enhance community efforts in controlling these pests through improved communication and collaboration among local entities. The project will implement a trial in Arequipa, Peru, utilizing a randomized cluster design to compare this new method against traditional pest control strategies. By integrating participatory research with computational sciences, the study seeks to create sustainable solutions for urban health challenges.
Who could benefit from this research
Good fit: Ideal candidates for this research include residents of urban areas affected by disease-carrying insects, particularly those in regions like Arequipa, Peru.
Not a fit: Patients living in rural areas or regions not impacted by urban disease vectors may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and sustainable methods for controlling disease vectors in urban environments, ultimately improving public health.
How similar studies have performed: Other research has shown promise in using biological models, like the immune system, to address pest control, suggesting potential for success in this innovative approach.
Where this research is happening
Philadelphia, United States
- University of Pennsylvania — Philadelphia, United States (Active)
Researchers
- Principal investigator: Levy, Michael Z — University of Pennsylvania
- Study coordinator: Levy, Michael Z
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.